Polo-like kinase inhibition as a therapeutic target in acute myeloid leukemia

Podobne zapisy

• Targeting polo-like kinase 1 in acute myeloid leukemia
  od: Brandwein, Joseph M.
  Wydane: (2015)
• Following in the footsteps of acute myeloid leukemia: Are we witnessing the start of a therapeutic revolution for higher-risk myelodysplastic syndromes?
  od: Bewersdorf, Jan Philipp, i wsp.
  Wydane: (2020)
• Epigenetic therapy combinations in acute myeloid leukemia: what are the options?
  od: Bewersdorf, Jan Philipp, i wsp.
  Wydane: (2019)
• Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
  od: Jan Philipp Bewersdorf, i wsp.
  Wydane: (2020-10-01)
• Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
  od: Bewersdorf, Jan Philipp, i wsp.
  Wydane: (2020)